Connect With Us

Inside INdiana Business
Subscribe Now Log In
  • Home
  • News
    • Education
    • Health
    • Tech
    • STEM
    • Advanced Manufacturing & Logistics
    • Life Sciences
    • Ag INnovation
    • INPower
  • Videos
  • Big Wigs
    • Submit Big Wigs
  • Events
    • Engage Central Indiana – Indianapolis
    • Engage Northeast Indiana – Fort Wayne
    • Engage West Central Indiana – Terre Haute
    • Engage Greater Lafayette – West Lafayette
    • Engage Northwest Indiana – Valparaiso
    • Engage South Bend – Elkhart
    • Engage Southwest Indiana – Evansville
  • Newsletters
  • Podcasts
  • On-Air
    • TV & Radio Listings
  • Contact
    • About IIB
    • Meet the Team
    • Contact Us
    • Advertise
    • Gift Cards
    • Flagship Stations
    • Gerry’s Message
    • Speaking Engagement Request

Connect With Us

Manchester U. Launches First-of-Its-Kind Degree

Monday, November 16, 2015 04:47 PM EDT Updated: Tuesday, November 17, 2015 08:36 AM EDT
Manchester U. Launches First-of-Its-Kind Degree David Kisor is leading the program at Manchester University.

The director of Manchester University’s new pharmacogenomics master’s program says graduates will be entering what experts estimate could be a $26 billion industry by 2021. David Kisor says the degree will prepare students on all aspects of the field from gathering DNA samples to analyzing data to reporting results to clinicians. Pharmacogenomics is the study of how genes affect a person’s response to drugs. The school believes it is the first master’s of its kind in the country.

The school says the one-year program will empower future physicians and clinicians to identify correct medications and to optimize an individual’s drug therapy early on. Completing the degree will open graduates up for careers in biological technology, genetic testing laboratories, the pharmaceutical industry or help give current researchers or health care professionals a "head start" toward more medicine, counseling or pharmacy professions.

"The Master of Science in Pharmacogenomics Program is designed for individuals with an undergraduate science degree or a professional degree in health care or health sciences,” says Kisor. "Manchester’s program offers individuals a pathway to this transformative field of medicine." He says it can help replace the "trial-and-error" approach currently implemented by doctors, other clinicians and pharmacists when prescribing medications. The result, MU says, is lower medication costs and reduced side effects. Pharmacogenomics skills translate across the therapeutic spectrum, including cardiology, psychiatry and cancer treatment.

Classes will begin in the summer. The program is located at MU’s Fort Wayne campus and Kisor envisions it will initially enroll eight to 12 students and grow to include around two dozen within 5 years.

MU Vice President for Institutional Effectiveness and College of Pharmacy, Natural and Health Sciences Dean Raylene Rospond says "this is a unique opportunity for individuals looking for a specialized field of health care that is poised for exciting growth and world-changing potential."

You can connect to more about the program by clicking here.

Story Continues Below

Manchester University Pharmacogenomics Master’s Program Director David Kisor says this program could connect to jobs in the state.
Your browser does not support the audio element.

Most Popular Stories

  • First female medical director takes the reins at IMS

  • State legislator arrested on suspicion of drunken driving

  • Hoosier Medicaid recipients report higher program dissatisfaction than peers

  • Helping Hoosier businesses build bigger: An often overlooked program can help

  • Old National relocating Louisville office after mass shooting

  • Keystone holds groundbreaking ceremony for $1B Eleven Park

Perspectives

Helping Hoosier businesses build bigger: An often overlooked program can help

Helping Hoosier businesses build bigger: An often overlooked program can help

Experts are predicting that volatility in the economy will continue for the remainder of the year. Consumers are faced with inflation and fluctuating interest rates, with at least one more rate increase predicted to “cool off” the overheated economy. Businesses are also paying close attention to interest rates, especially entrepreneurs looking to launch or expand businesses....

Inside INdiana Business

Inside INdiana Business
A division of IBJ Media

1 Monument Circle, Suite 300
Indianapolis, IN 46204

PHONE: (317) 634-6200

FAX: (317) 263-5060

NEWSLETTER@IIBNEWS.COM

  • Home
  • News
  • Videos
  • Gerry Dick
  • Newsletters
  • On-Air
  • Contact

Copyright © 2023 All Rights Reserved Privacy Policy | Terms of Service